Abstract
This chapter describes the in vivo delivery of conventional mRNA or alphaviral replicon RNA via intradermal electroporation. The use of RNA in clinical applications has several potential advantages compared to DNA. For instance, RNA cannot integrate into the host genome, and it does not contain bacterial sequence motifs such as CpG often present in plasmid DNA backbones that can potentially trigger autoimmune responses. Intradermal electroporation is well tolerated and causes only minor trauma compared to intramuscular electroporation. As the skin houses high concentrations of antigen-presenting cells, vaccines could especially benefit from intradermal administration of RNA.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gilkeson GS, Grudier JP, Karounos DG et al (1989) Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142:1482–1486
Gilkeson GS, Grudier JP, Pisetsky DS (1989) The antibody response of normal mice to immunization with single-stranded DNA of various species origin. Clin Immunol Immunopathol 51:362–371
Gilkeson GS, Pritchard AJ, Pisetsky DS (1991) Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Clin Immunol Immunopathol 59:288–300
Gilkeson GS, Pippen AM, Pisetsky DS (1995) Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 95:1398–1402
Roos AK, Eriksson F, Timmons JA et al (2009) Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One 4:e7226
Pisetsky DS (1996) Immune activation by bacterial DNA: a new genetic code. Immunity 5:303–310
Nordstrom EK, Forsell MN, Barnfield C et al (2005) Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J Gen Virol 86:349–354
Berglund P, Smerdou C, Fleeton MN et al (1998) Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 16:562–565
Ljungberg K, Whitmore AC, Fluet ME et al (2007) Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine. J Virol 81:13412–13423
Dubensky TW Jr, Driver DA, Polo JM et al (1996) Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer. J Virol 70:508–519
Hariharan MJ, Driver DA, Townsend K et al (1998) DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector. J Virol 72:950–958
Knudsen ML, Mbewe-Mvula A, Rosario M et al (2012) Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. J Virol 86:4082–4090
Fleeton MN, Chen M, Berglund P et al (2001) Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus. J Infect Dis 183:1395–1398
Geall AJ, Verma A, Otten GR et al (2012) Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci USA 109:14604–14609
Schulz O, Diebold SS, Chen M et al (2005) Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433:887–892
Schulz O, Pichlmair A, Rehwinkel J et al (2010) Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7:354–361
Weiss R, Scheiblhofer S, Roesler E et al (2010) Prophylactic mRNA vaccination against allergy. Curr Opin Allergy Clin Immunol 10:567–574
Widera G, Austin M, Rabussay D et al (2000) Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164:4635–4640
Piggott JM, Sheahan BJ, Soden DM et al (2009) Electroporation of RNA stimulates immunity to an encoded reporter gene in mice. Mol Med Rep 2:753–756
Johansson DX, Ljungberg K, Kakoulidou M et al (2012) Intradermal electroporation of naked replicon RNA elicits strong immune responses. PLoS One 7:e29732
Roos AK, Eriksson F, Walters DC et al (2009) Optimization of skin electroporation in mice to increase tolerability of DNA vaccine delivery to patients. Mol Ther 17:1637–1642
Roos AK, Moreno S, Leder C et al (2006) Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation. Mol Ther 13:320–327
Acknowledgements
This project was supported by the Swedish Research Council and Swedish International Development Cooperation Agency.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Knudsen, M.L., Ljungberg, K., Liljeström, P., Johansson, D.X. (2014). Intradermal Electroporation of RNA. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols